GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QHSLab Inc (OTCPK:USAQ) » Definitions » Forward PE Ratio

QHSLab (QHSLab) Forward PE Ratio : 0.00 (As of May. 26, 2024)


View and export this data going back to 1990. Start your Free Trial

What is QHSLab Forward PE Ratio?

QHSLab's Forward PE Ratio for today is 0.00.

QHSLab's PE Ratio without NRI for today is 0.00.

QHSLab's PE Ratio for today is 0.00.


QHSLab Forward PE Ratio Historical Data

The historical data trend for QHSLab's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QHSLab Forward PE Ratio Chart

QHSLab Annual Data
Trend 2020-12 2021-12 2022-09
Forward PE Ratio
23.15 6.00 1.08

QHSLab Quarterly Data
2020-12 2021-03 2021-09 2021-12
Forward PE Ratio 23.15 14.99 8.00 6.00

Competitive Comparison of QHSLab's Forward PE Ratio

For the Medical Devices subindustry, QHSLab's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QHSLab's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QHSLab's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where QHSLab's Forward PE Ratio falls into.



QHSLab Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


QHSLab  (OTCPK:USAQ) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


QHSLab Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of QHSLab's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


QHSLab (QHSLab) Business Description

Traded in Other Exchanges
N/A
Address
901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. It is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
Executives
Troy James Grogan director, 10 percent owner, officer: CEO/Director 5480 N OCEAN DR B1D, SINGER ISLAND FL 33404
Richard J Rubin director, 10 percent owner, officer: CEO & Chairman 90 JOHN STREET, SUITE 626, NEW YORK NY 10038

QHSLab (QHSLab) Headlines

From GuruFocus